Expand public claims only after the operating evidence
Review the entire offer before adding a nation or broader region: pages, booking rules, clinical forms, partner messages, and staff instructions. They should describe the same supported scope and distinguish confirmed arrangements from planned development.
Apply MHRA medicines-advertising guidance to treatment-related promotion. A wider geographic label does not remove restrictions on public promotion of prescription-only medicines. Avoid claims of guaranteed treatment or uniform access that the assessed model cannot support. MHRA: advertise your medicines
During the Dundee pilot, review complete episodes and the work needed when patients fall outside the intended arrangements. Use the findings to improve the starting service before multiplying its geography. A successful first appointment does not prove that referrals, results, and aftercare work across a larger area.
Keep a dated expansion record with qualified advice, partner confirmation, and practical tests. Retest after material changes. Growth should be an evidence-based extension of a functioning provider model, not merely the addition of place names to a website that still depends on one unexamined set of clinical assumptions.